Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.

Shilpa Medicare has launched its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers as well as peptides – with oncology a ...

Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases where protein growth ...

Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...

The 86-patient CD10 trial looked at the antibody's potential in mild-to-moderate COVID-19, but failed to show a benefit on any measures, including the primary endpoint of "total clinical symptom ...

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such ...

Materials in the nanometer range have been produced for several decades. Carbon Black, for example, has been used in tires since 1930. Today, the production capabilities for specially designed ...

Feb. 17, 2025 — In a surprising discovery, scientists have found that the heart possesses 'sweet taste' receptors, similar to those on our tongues, and that stimulating these receptors with ...